Fox Run Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fox Run Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$321K	Buy
2016 Q4	–	Sell
2016 Q3	$230K	Buy
2016 Q2	$180K	Buy